Tag: Prescription Drugs
ALS Drug Relyvrio May Be Pulled From Market
Manufacturer may pull medication from the market following lackluster results from a large trial
Nirsevimab Effective for Preventing RSV-Linked Hospitalization
Single dose of nirsevimab 90 percent effective against RSV-associated hospitalization among infants
FDA Approves Wegovy to Lower Risk for CVD Events in Patients With Obesity
Agency's action could widen access to the drug if more insurance companies decide to cover it
Survival Up With Enfortumab Vedotin + Pembrolizumab in Urothelial Cancer
Significantly longer progression-free and overall survival seen in patients with previously untreated locally advanced or metastatic urothelial carcinoma
Benralizumab Noninferior to Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis
Benralizumab is noninferior, but not superior, for adults with eosinophilic granulomatosis with polyangiitis receiving standard care
Tacrolimus Microemulsion Has Good Efficacy, Safety for Scalp Psoriasis
Investigator Global Assessment of 0 or 1 occurred in significantly more patients receiving tacrolimus microemulsion versus placebo
Mixed Digital Intervention Increases HIV Prevention Adherence in Young People
Combo of one-on-one telehealth coaching, peer support forums, and automated text messages can double PrEP uptake
2015 to 2021 Saw Marked Rise in PCSK9 Inhibitor Utilization
Yet prescription rates remain substantially lower than that seen for other guideline-recommended cardiometabolic therapies
Top-Down Treatment Superior for Crohn Disease
One-year outcomes better with early combined infliximab + immunomodulator vs. accelerated step-up treatment
Exercise Key to Maintaining Weight Loss After Stopping GLP-1 Receptor Agonists
Findings seen for body weight, body fat percentage, weight loss, and weight regain
